| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C0039711> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34855968_HAS_TOPIC_C5544360>
?:authorAffiliation	[]
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Price_Sean>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Texas medicine
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34855968>
?:pmid	<https://research.tib.eu/covid-19/entity/34855968>
?:pmid	34855968
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.105
?:rankingScore_hIndex	13
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0020964_PROCESS_OF_C0027361>
?:title	Talk to Patients About: Breakthrough Infections.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34855968>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34855968>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all